BayWa's New Zealand Apple Sale Stalls as a Minority Shareholder Blunts the Rescue Plan

German conglomerate BayWa's restructuring faces hurdles as minority investor blocks sale of its T&G apple orchard stake, while a €2.7 billion gap from canceled US subsidies and legal probes deepen the crisis.

The fate of BayWa’s restructuring drive now runs through a small apple orchard in New Zealand — and a minority investor that refuses to budge. The German agricultural conglomerate has been trying since March to sell its 74% stake in T&G Global, the fruit marketing giant behind the Envy and Jazz apple brands, which reaches more than 60 countries and generated US$1.3 billion in revenue last year. But the process, managed by Goldman Sachs, is running into resistance from Joy Wing Mau, the Chinese fruit distributor that holds a one-fifth stake in T&G and is blocking a speedy exit.

BayWa expects the sale to bring in around €300 million and shave more than €600 million off its bank debt. T&G’s operating profit climbed to NZ$12.7 million in 2024, a sign the business is improving, but that has not been enough to persuade the minority holder to cooperate. Potential buyers circling the asset include private equity firms Paine Schwartz, Roc Partners and Hancock, yet the deal remains stalled at a moment when BayWa can least afford delays.

Even a successful T&G disposal, however, would only scratch the surface of the company’s deeper problem. A chasm of roughly €2.7 billion still gapes in the restructuring plan, caused primarily by the abrupt cancellation of US subsidies for the renewable energy projects of subsidiary BayWa r.e. That policy reversal has wiped out what was supposed to be the group’s biggest single remedy: the planned sale of a majority stake in r.e., originally valued at around €1.7 billion. With that deal off the table, BayWa is now forced to chip away at its mountain of liabilities through a series of smaller asset sales, which have so far reduced bank borrowings by about €1.3 billion.

Meanwhile, legal pressure is intensifying on multiple fronts. Munich prosecutors have opened investigations into former chief executives Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and false balance-sheet reporting — allegations both men deny. Shareholders have filed class-action lawsuits over risks they say were concealed, and Germany’s financial regulator BaFin had already flagged omissions in the 2023 annual report. The audit supervisor Apas has launched a professional conduct probe into PwC, the group’s longtime auditor, after it issued an unqualified opinion for 2023 without warning of existential threats. BayWa has now put the PwC mandate out to tender for 2026 and is examining its own potential damage claims against the firm.

Operationally, management is slashing hard. Around 1,300 jobs are being cut and dozens of local offices closed as the group aims to shrink from a company that once booked nearly €24 billion in revenue to a leaner agricultural and building-materials trader turning over roughly €10 billion by 2028. The adjusted EBITDA target for 2027 has been set at around €140 million, and BayWa has withdrawn its full-year guidance for 2026 entirely. The first real test of whether these cuts are working will come on 26 May, when the quarterly report lands.

On the Frankfurt exchange, the stock closed at €13.05 on Friday, down more than a fifth since the start of the year. The annualised 30-day volatility has spiked above 90%, reflecting the extreme uncertainty hanging over the company.

That uncertainty will come to a head this autumn. BayWa needs DZ Bank and UniCredit to agree on an extension of the standstill agreement that keeps the restructuring plan legally viable. Without that renewal — and without an audited 2025 annual report in hand by then — the entire turnaround strategy loses its foundation. The next few months will determine whether the board can convince its lenders that enough progress has been made on debt reduction, even as a minority shareholder in a New Zealand orchard continues to hold up one of the few visible cash infusions on the horizon.